5:12 PM
 | 
Oct 11, 2013
 |  BC Extra  |  Company News

Auxilium to market Vivus' ED drug in U.S., Canada

Vivus Inc. (NASDAQ:VVUS) granted Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL) exclusive rights to commercialize erectile dysfunction (ED) drug Stendra avanafil in the U.S....

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >